The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Establishing analytical and clinical similarity between HD201 and herceptin.
 
Jocelyn Hii
Employment - Prestige BioPharma
 
Xavier Pivot
Consulting or Advisory Role - Prestige BioPharma
Research Funding - Prestige BioPharma
 
Kristi Mclendon
Consulting or Advisory Role - Prestige BioPharma
 
Kuo Wei Chan
Employment - Prestige BioPharma
Consulting or Advisory Role - Prestige BioPharma
 
Peggy Feyaerts
Employment - Prestige BioPharma
 
Jeong-Hyeon Lee
Employment - Prestige BioPharma
 
Felicia Ang
Employment - Prestige BioPharma
 
Martin Demarchi
No Relationships to Disclose
 
Pierre Coliat
Travel, Accommodations, Expenses - Merck Serono
 
Filip Deforce
Employment - DICE
Leadership - DICE
Stock and Other Ownership Interests - DICE
Consulting or Advisory Role - DICE
Travel, Accommodations, Expenses - DICE
Other Relationship - Prestige BioPharma
(OPTIONAL) Uncompensated Relationships - Prestige BioPharma
 
Marie_Paule Derde
Employment - DICE
 
Michael J Kim
Employment - Prestige BioPharma
Leadership - Prestige BioPharma
Stock and Other Ownership Interests - Prestige BioPharma
Travel, Accommodations, Expenses - Prestige BioPharma
 
Lisa Soyeon Park
Employment - Prestige BioPharma
Leadership - Prestige BioPharma
Stock and Other Ownership Interests - Prestige BioPharma
Travel, Accommodations, Expenses - Prestige BioPharma